MPLN News


MPLN’s Geneuity Division Adopts Thermo Fisher’s Oncomine Assay to Expand Pharmaceutical Services

Posted on July 15 2015 by J Seabrook

Maryville, Tennessee – (July 15, 2015)(Business Wire). Geneuity today…
Read more


New Guideline Advances Standardization of EGFR Mutation and ALK-Rearrangement Testing in Lung Cancer

Posted on November 20 2014 by J Seabrook

New guidance, endorsed by ASCO, outlines patient selection criteria for treatment of advanced-stage lung adenocarcinoma or tumors with an adenocarcinoma component with EGFR or ALK inhibitors based on EFGR mutation and ALK rearrangement. The guideline…
Read more


Illumina.jpg

MPLN ACQUIRES THE FIRST FDA APPROVED HIGH THROUGHPUT DNA SEQUENCING ANALYZER

Posted on October 03 2014 by Jonathan Mulkey

Molecular Pathology Laboratory Network, Inc. (MPLN) acquires the Illumina MiSeqDx™ next generation sequencing system to expand its portfolio of molecular testing and clinical research services to support growing demand in personalized medicine.


Read more
1 2 3 next →